FMC-NA Names Joe Turk New President for Renal Therapies Group

Joseph (Joe) Turk succeeds Mark Constanzo, who recently retired, as the new President for the Fresenius Medical Care North America Renal Therapies Group, and will now oversee the renal products and pharmaceutical operations.

Read the full article » | Posted 08-12-2021

Related Articles

• Watch a 2-minute video of Dr. Brigitte Schiller describing a paper on nocturnal home HD Posted 08-21-2026
• The Quanta Dialysis System for home HD is the first FDA 510(k) approved machine that offers high (500 mL/min) dialysate flow Posted 08-21-2026
• The American Kidney Fund’s Kidney Action Week: Future of Kidney Care is September 8-10. Posted 08-21-2026
• On August 9, CMS published “Regulatory Alignment for Predictable and Immediate Device Coverage Pathway (CMS-3487-NC) Procedural Notice Inviting Comment.” Posted 08-21-2026